This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Victoza
  • /
  • Liraglutide Effect and Action in Diabetes: Evaluat...
Clinical trial

Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results (LEADER�)

Read time: 2 mins
Last updated:31st Aug 2010
Identifier: NCT01179048

This trial is conducted in Africa, Asia, Europe, and North and South America. The aim of this trial is to determine the long term effect of liraglutide on cardiovascular events in subjects with type 2 diabetes.


Study Type: Interventional  (Clinical Trial)
Actual Enrollment: 9340 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Investigator)
Primary Purpose: Treatment
Official Title:  Long-term, Multi-centre, International, Randomised Double-blind, Placebo-controlled Trial to Determine Liraglutide Effects on Cardiovascular Events
Actual Study Start Date: August 31, 2010
Actual Primary Completion Date: December 17, 2015
Actual Study Completion Date: December 17, 2015

Arms:
- Experimental:
Liraglutide
- Placebo Comparator: Placebo

Category Value
Date last updated at source 2019-01-01
Study type(s) Interventional
Expected enrolment 9340
Study start date 2010-08-31
Estimated primary completion date 2015-12-17

View full details